I have had the same luck you have regarding our searches.
Maybe Harvard will be able to help. The agreement calls for a large commitment of units to be sold during the next 3 years. 50 to be exact. At the going rate, that equals $12,500,000 or a little over $4,000,000 a year.
Imaging Diagnostic Systems Reports Sales at RSNA Medical Conference For the Millennium
FORT LAUDERDALE, Fla., Dec. 1 /PRNewswire/ -- Imaging Diagnostic Systems Inc. (OTC Bulletin Board: IMDS) announced today that it has received the first signed and funded orders for its CT Laser Mammography system. The corporation Cycle of Life Technologies, based in Toronto, Canada, has signed an agreement for two systems totaling $500,000 in revenues with the delivery of two additional systems immediately following.
The Cycle of Life Technologies has signed a three-year distribution agreement with a commitment of fifty systems to be delivered within two
years. Their distribution channel encompasses an extensive network of
international hospitals and physician practices. They are the primary
suppliers for various medical services and equipment throughout Canada,
Europe, South Africa and the Middle East. Cycle of Life Technologies is
also involved in the development of DNA diagnostics and gene therapy
with ACGT Corporation of Canada and Harvard Medical School.
Imaging Diagnostic Systems has committed to commence delivery of the
first CTLM systems in the first quarter of the millennium. This will be
the first revenues generated for Imaging Diagnostic Systems since the
inception of the company.
Imaging Diagnostic Systems has developed the world's first patented
laser-based mammography imaging system that utilizes state-of-the-art
laser technology and proprietary computed algorithms to create
contiguous cross sectional slice images of the breast without the use of
compression or x-rays.
Safe Harbor statement under the Private Securities Litigation Reform Act
of 1995: The statements which are not historical facts contained in this
press release are forward-looking statements that involve certain risks
and uncertainties including, but not limited to, risks associated with
the uncertainties of future events and other uncertainties detailed in
the Company's filings with the Security and Exchange Commission.
------------------------------------------------------------------------
SOURCE: ÿImaging Diagnostic Systems Inc.
CONTACT: ÿDeborah O'Brien of Imaging Diagnostic Systems Inc.,
954-581-9800 |
